TRAW vs ULTA · rev $2.8M vs P/E 17, rev $3.04B
Traws Pharma Inc (TRAW) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
Latest reported ULTA revenue for 2026-08-01 was $3.04B. Net income was $282.0M. Revenue was down 4.1% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
TRAW currently screens at market cap $12.1M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the TRAW and ULTA stock pages for the full models.
Not investment advice.